AAMAC is developing a submission for the pan-Canadian Oncology Drug Review for orally administered/tablets for the treatment of #MDS
We are specifically seeking input from patients with experience with treatments for MDS including oral #decitabine (INQOVI).
The survey can be found at
Please complete the survey by August 13, 2020
Thank you for your participation!